Development of and clinical experience with capecitabine (Xeloda®) in the treatment of solid tumours

Development of and clinical experience with capecitabine (Xeloda®) in the treatment of solid tumours is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Development of and clinical experience with capecitabine (Xeloda®) in the treatment of solid tumours have?

Development of and clinical experience with capecitabine (Xeloda®) in the treatment of solid tumours has 16 citations in the OpenAlex counts ScholarIQ stores.

When was Development of and clinical experience with capecitabine (Xeloda®) in the treatment of solid tumours published?

Development of and clinical experience with capecitabine (Xeloda®) in the treatment of solid tumours has 2004 year in the ScholarIQ index.

What is the open-access status of Development of and clinical experience with capecitabine (Xeloda®) in the treatment of solid tumours?

Development of and clinical experience with capecitabine (Xeloda®) in the treatment of solid tumours has closed oa status in the ScholarIQ index.

What is the DOI of Development of and clinical experience with capecitabine (Xeloda®) in the treatment of solid tumours?

The DOI for Development of and clinical experience with capecitabine (Xeloda®) in the treatment of solid tumours is on the source record.

What is the PMID of Development of and clinical experience with capecitabine (Xeloda®) in the treatment of solid tumours?

The PMID for Development of and clinical experience with capecitabine (Xeloda®) in the treatment of solid tumours is on the source record.

What is the OpenAlex record for Development of and clinical experience with capecitabine (Xeloda®) in the treatment of solid tumours?

The OpenAlex for Development of and clinical experience with capecitabine (Xeloda®) in the treatment of solid tumours is on the source record.